| 0 |
ANTACID THERAPY |
44 |
0.3385 |
| 1 |
SLEEP DISORDER THERAPY |
64 |
0.3232 |
| 2 |
BRIEF PSYCHOTIC DISORDER WITHOUT MARKED STRESSORS |
1 |
0.2500 |
| 3 |
CONGENITAL HIATUS HERNIA |
50 |
0.2193 |
| 4 |
ANALGESIC THERAPY |
62 |
0.1931 |
| 5 |
MALIGNANT MELANOMA STAGE 0 |
39 |
0.1866 |
| 6 |
DRUG THERAPY |
60 |
0.1770 |
| 7 |
APPENDICOLITH |
65 |
0.1680 |
| 8 |
ANTICOAGULANT THERAPY |
44 |
0.1549 |
| 9 |
VAGINAL FLATULENCE |
35 |
0.1155 |
| 10 |
FASCIA RELEASE |
1 |
0.1000 |
| 11 |
BACTEROIDES INFECTION |
19 |
0.0728 |
| 12 |
FERTILITY INCREASED |
1 |
0.0588 |
| 13 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
42 |
0.0453 |
| 14 |
HYPERPHOSPHATAEMIA |
75 |
0.0349 |
| 15 |
HYPONATRAEMIC COMA |
1 |
0.0278 |
| 16 |
URINE SODIUM INCREASED |
5 |
0.0236 |
| 17 |
CERULOPLASMIN DECREASED |
1 |
0.0233 |
| 18 |
BLOOD PHOSPHORUS INCREASED |
56 |
0.0205 |
| 19 |
FEMALE GENITAL TRACT FISTULA |
35 |
0.0205 |
| 20 |
SCROTAL CELLULITIS |
1 |
0.0175 |
| 21 |
OROPHARYNGEAL DISCOLOURATION |
1 |
0.0172 |
| 22 |
TOTAL LUNG CAPACITY DECREASED |
25 |
0.0156 |
| 23 |
OCHRONOSIS |
1 |
0.0141 |
| 24 |
PLEURITIC PAIN |
38 |
0.0138 |
| 25 |
RADICULOPATHY |
35 |
0.0133 |
| 26 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
67 |
0.0132 |
| 27 |
MENTAL RETARDATION SEVERITY UNSPECIFIED |
1 |
0.0130 |
| 28 |
SEPTAL PANNICULITIS |
1 |
0.0125 |
| 29 |
PROCTITIS |
35 |
0.0125 |
| 30 |
RESPIRATORY SYMPTOM |
35 |
0.0123 |
| 31 |
POST GASTRIC SURGERY SYNDROME |
1 |
0.0111 |
| 32 |
HYPOPHOSPHATAEMIA |
81 |
0.0109 |
| 33 |
LEPTOSPIROSIS |
1 |
0.0109 |
| 34 |
STAG HORN CALCULUS |
1 |
0.0105 |
| 35 |
MYASTHENIA GRAVIS |
84 |
0.0104 |
| 36 |
POSTOPERATIVE THORACIC PROCEDURE COMPLICATION |
1 |
0.0103 |
| 37 |
IMAGING PROCEDURE ABNORMAL |
1 |
0.0100 |
| 38 |
SUBACUTE ENDOCARDITIS |
1 |
0.0097 |
| 39 |
BLOOD URIC ACID INCREASED |
55 |
0.0095 |
| 40 |
CHRONIC SINUSITIS |
35 |
0.0093 |
| 41 |
IRON DEFICIENCY |
41 |
0.0091 |
| 42 |
IRON BINDING CAPACITY TOTAL DECREASED |
2 |
0.0090 |
| 43 |
DRUG-DEVICE INTERACTION |
1 |
0.0090 |
| 44 |
LUNG OPACITY |
23 |
0.0087 |
| 45 |
VITREOUS ADHESIONS |
1 |
0.0087 |
| 46 |
LIVER FUNCTION TEST |
1 |
0.0085 |
| 47 |
COPPER DEFICIENCY |
1 |
0.0083 |
| 48 |
AORTIC STENOSIS |
29 |
0.0083 |
| 49 |
OESOPHAGEAL DISCOMFORT |
6 |
0.0079 |
| 50 |
BENIGN PROSTATIC HYPERPLASIA |
41 |
0.0079 |
| 51 |
BREATH SOUNDS ABNORMAL |
37 |
0.0075 |
| 52 |
TROPONIN INCREASED |
54 |
0.0071 |
| 53 |
APPENDICITIS |
65 |
0.0070 |
| 54 |
HEPATOSPLENIC CANDIDIASIS |
1 |
0.0068 |
| 55 |
CORONARY REVASCULARISATION |
1 |
0.0063 |
| 56 |
WOUND NECROSIS |
3 |
0.0062 |
| 57 |
BLOOD OSMOLARITY INCREASED |
2 |
0.0061 |
| 58 |
SCROTAL ERYTHEMA |
1 |
0.0060 |
| 59 |
BLOOD CALCIUM INCREASED |
52 |
0.0059 |
| 60 |
VENTRICULAR FIBRILLATION |
65 |
0.0058 |
| 61 |
VENTRICULAR ASYSTOLE |
1 |
0.0057 |
| 62 |
TRACHEOSTOMY MALFUNCTION |
1 |
0.0048 |
| 63 |
SCROTAL INFECTION |
1 |
0.0048 |
| 64 |
IMMOBILISATION SYNDROME |
1 |
0.0047 |
| 65 |
BACTERIAL INFECTION |
84 |
0.0045 |
| 66 |
NEUROMUSCULAR BLOCKADE |
1 |
0.0045 |
| 67 |
HYPERLIPIDAEMIA |
53 |
0.0044 |
| 68 |
CARDIOGENIC SHOCK |
63 |
0.0044 |
| 69 |
NASAL ABSCESS |
1 |
0.0043 |
| 70 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
74 |
0.0043 |
| 71 |
FAT REDISTRIBUTION |
1 |
0.0043 |
| 72 |
ASPARTATE AMINOTRANSFERASE |
1 |
0.0041 |
| 73 |
WITHDRAWAL BLEEDING IRREGULAR |
1 |
0.0041 |
| 74 |
PLANTAR ERYTHEMA |
1 |
0.0040 |
| 75 |
ASPIRATION |
42 |
0.0038 |
| 76 |
HYPERCHOLESTEROLAEMIA |
37 |
0.0038 |
| 77 |
BLOOD TEST ABNORMAL |
52 |
0.0037 |
| 78 |
PALPABLE PURPURA |
1 |
0.0036 |
| 79 |
ULCER |
57 |
0.0036 |
| 80 |
VAGINAL DISCHARGE |
36 |
0.0036 |
| 81 |
MEDICAL DEVICE SITE HAEMORRHAGE |
1 |
0.0035 |
| 82 |
FULL BLOOD COUNT ABNORMAL |
37 |
0.0035 |
| 83 |
NEURALGIA |
84 |
0.0035 |
| 84 |
END STAGE RENAL DISEASE |
63 |
0.0035 |
| 85 |
MICTURITION URGENCY |
39 |
0.0034 |
| 86 |
DROP ATTACKS |
2 |
0.0034 |
| 87 |
VAGAL NERVE STIMULATOR IMPLANTATION |
1 |
0.0033 |
| 88 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
90 |
0.0032 |
| 89 |
GOUT |
57 |
0.0032 |
| 90 |
NAIL BED INFLAMMATION |
1 |
0.0031 |
| 91 |
CENTRAL HYPOTHYROIDISM |
1 |
0.0030 |
| 92 |
BLOOD VISCOSITY DECREASED |
1 |
0.0030 |
| 93 |
INFLAMMATION OF WOUND |
1 |
0.0030 |
| 94 |
MACULAR DEGENERATION |
35 |
0.0029 |
| 95 |
MECONIUM IN AMNIOTIC FLUID |
1 |
0.0028 |
| 96 |
IDIOPATHIC INTERSTITIAL PNEUMONIA |
1 |
0.0028 |
| 97 |
ALLERGY TO ANIMAL |
3 |
0.0028 |
| 98 |
BRAIN MALFORMATION |
1 |
0.0028 |
| 99 |
DYSPLASTIC NAEVUS |
1 |
0.0028 |
| 100 |
ESCHAR |
2 |
0.0027 |
| 101 |
XANTHOPSIA |
1 |
0.0027 |
| 102 |
ORAL CANDIDIASIS |
35 |
0.0027 |
| 103 |
SCROTAL ABSCESS |
1 |
0.0026 |
| 104 |
HUMIDITY INTOLERANCE |
1 |
0.0025 |
| 105 |
PARAESTHESIA ORAL |
36 |
0.0025 |
| 106 |
SINONASAL OBSTRUCTION |
1 |
0.0025 |
| 107 |
MANUFACTURING MATERIALS ISSUE |
1 |
0.0025 |
| 108 |
RETICULOCYTE COUNT DECREASED |
1 |
0.0023 |
| 109 |
GENITAL BURNING SENSATION |
2 |
0.0023 |
| 110 |
ASCITES |
66 |
0.0022 |
| 111 |
ADRENAL NEOPLASM |
1 |
0.0021 |
| 112 |
KLEBSIELLA BACTERAEMIA |
2 |
0.0021 |
| 113 |
CONGENITAL HYDROCEPHALUS |
1 |
0.0020 |
| 114 |
MENINGITIS LISTERIA |
1 |
0.0020 |
| 115 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
2 |
0.0019 |
| 116 |
OSTEOMYELITIS ACUTE |
1 |
0.0018 |
| 117 |
JOINT INJURY |
39 |
0.0018 |
| 118 |
BLOOD MAGNESIUM ABNORMAL |
1 |
0.0018 |
| 119 |
HYPONATRAEMIA |
98 |
0.0017 |
| 120 |
PLATELET COUNT |
1 |
0.0017 |
| 121 |
NASAL MUCOSAL DISORDER |
1 |
0.0017 |
| 122 |
TRANSAMINASES INCREASED |
38 |
0.0017 |
| 123 |
DEVICE MAINTENANCE ISSUE |
1 |
0.0017 |
| 124 |
MENINGOMYELOCELE |
1 |
0.0017 |
| 125 |
MALIGNANT MELANOMA IN SITU |
2 |
0.0016 |
| 126 |
BLOOD OSMOLARITY DECREASED |
1 |
0.0016 |
| 127 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
82 |
0.0016 |
| 128 |
INFUSION SITE IRRITATION |
2 |
0.0016 |
| 129 |
RALES |
9 |
0.0015 |
| 130 |
ENTEROCOCCUS TEST POSITIVE |
1 |
0.0015 |
| 131 |
ALLERGIC OEDEMA |
1 |
0.0015 |
| 132 |
SPINAL CORD INFECTION |
1 |
0.0015 |
| 133 |
KLEBSIELLA TEST POSITIVE |
1 |
0.0015 |
| 134 |
OESOPHAGEAL PAIN |
6 |
0.0015 |
| 135 |
PAINFUL DEFAECATION |
1 |
0.0014 |
| 136 |
CARDIOVASCULAR DISORDER |
36 |
0.0014 |
| 137 |
BORDERLINE PERSONALITY DISORDER |
1 |
0.0014 |
| 138 |
ALPHA 1 FOETOPROTEIN INCREASED |
1 |
0.0014 |
| 139 |
CEREBELLAR HAEMORRHAGE |
2 |
0.0014 |
| 140 |
PROTEUS INFECTION |
1 |
0.0014 |
| 141 |
ANTIBODY TEST ABNORMAL |
1 |
0.0014 |
| 142 |
BLUNTED AFFECT |
1 |
0.0014 |
| 143 |
CORONARY ARTERY DISEASE |
41 |
0.0014 |
| 144 |
BRONCHIECTASIS |
9 |
0.0013 |
| 145 |
SUPERINFECTION |
2 |
0.0013 |
| 146 |
MYOGLOBIN BLOOD INCREASED |
2 |
0.0013 |
| 147 |
FREQUENT BOWEL MOVEMENTS |
35 |
0.0013 |
| 148 |
NEPHROGENIC ANAEMIA |
6 |
0.0013 |
| 149 |
GROWTH OF EYELASHES |
1 |
0.0013 |
| 150 |
RETICULOCYTE COUNT INCREASED |
1 |
0.0012 |
| 151 |
PROCEDURAL PAIN |
34 |
0.0012 |
| 152 |
BLOOD CHOLESTEROL INCREASED |
57 |
0.0012 |
| 153 |
TONGUE ERYTHEMA |
1 |
0.0012 |
| 154 |
DYSCHROMATOPSIA |
1 |
0.0012 |
| 155 |
LOWER RESPIRATORY TRACT INFECTION |
54 |
0.0012 |
| 156 |
SPUTUM DISCOLOURED |
11 |
0.0012 |
| 157 |
SLEEP DISORDER |
81 |
0.0011 |
| 158 |
TOXIC EPIDERMAL NECROLYSIS |
17 |
0.0011 |
| 159 |
CANDIDA SEPSIS |
1 |
0.0011 |
| 160 |
DIABETES MELLITUS |
85 |
0.0011 |
| 161 |
TRANSIENT ISCHAEMIC ATTACK |
37 |
0.0011 |
| 162 |
IRON DEFICIENCY ANAEMIA |
10 |
0.0011 |
| 163 |
THROMBOSIS |
85 |
0.0011 |
| 164 |
DEVICE RELATED THROMBOSIS |
1 |
0.0010 |
| 165 |
STOMA COMPLICATION |
1 |
0.0010 |
| 166 |
EYE COLOUR CHANGE |
1 |
0.0010 |
| 167 |
INTENTIONAL PRODUCT MISUSE |
85 |
0.0010 |
| 168 |
SWELLING |
88 |
0.0009 |
| 169 |
SMALL INTESTINAL STENOSIS |
1 |
0.0009 |
| 170 |
UPPER RESPIRATORY TRACT INFECTION |
43 |
0.0009 |
| 171 |
CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY |
1 |
0.0009 |
| 172 |
RENAL TUBULAR ACIDOSIS |
2 |
0.0009 |
| 173 |
DRUG INTOLERANCE |
87 |
0.0009 |
| 174 |
COLITIS |
34 |
0.0009 |
| 175 |
SEPSIS |
100 |
0.0009 |
| 176 |
BLOOD CREATININE INCREASED |
58 |
0.0009 |
| 177 |
CEREBRAL VENTRICLE DILATATION |
1 |
0.0009 |
| 178 |
CHEMICAL BURN |
1 |
0.0009 |
| 179 |
STREPTOCOCCAL SEPSIS |
1 |
0.0008 |
| 180 |
PULMONARY EMBOLISM |
80 |
0.0008 |
| 181 |
GENERAL PHYSICAL HEALTH DETERIORATION |
95 |
0.0008 |
| 182 |
RECTAL HAEMORRHAGE |
35 |
0.0008 |
| 183 |
LIVER DISORDER |
36 |
0.0008 |
| 184 |
OBSTRUCTIVE AIRWAYS DISORDER |
9 |
0.0008 |
| 185 |
RECTAL TENESMUS |
1 |
0.0008 |
| 186 |
LIVER FUNCTION TEST INCREASED |
17 |
0.0008 |
| 187 |
COLITIS ULCERATIVE |
35 |
0.0008 |
| 188 |
BLOOD CHLORIDE DECREASED |
2 |
0.0008 |
| 189 |
CARDIAC VENTRICULAR THROMBOSIS |
1 |
0.0008 |
| 190 |
DRY MOUTH |
62 |
0.0008 |
| 191 |
LUNG DISORDER |
37 |
0.0008 |
| 192 |
ANION GAP INCREASED |
1 |
0.0007 |
| 193 |
CARBON DIOXIDE INCREASED |
1 |
0.0007 |
| 194 |
INFUSION SITE RASH |
1 |
0.0007 |
| 195 |
RHONCHI |
1 |
0.0007 |
| 196 |
CULTURE URINE POSITIVE |
1 |
0.0007 |
| 197 |
ABDOMINAL DISTENSION |
73 |
0.0007 |
| 198 |
PHARYNGEAL DISORDER |
2 |
0.0007 |
| 199 |
FAT TISSUE INCREASED |
1 |
0.0007 |
| 200 |
BLOOD PARATHYROID HORMONE INCREASED |
2 |
0.0007 |
| 201 |
PULMONARY VALVE INCOMPETENCE |
1 |
0.0007 |
| 202 |
GENERALISED ANXIETY DISORDER |
1 |
0.0007 |
| 203 |
PRECANCEROUS SKIN LESION |
1 |
0.0007 |
| 204 |
RHINITIS ALLERGIC |
3 |
0.0007 |
| 205 |
NEPHRECTOMY |
1 |
0.0007 |
| 206 |
PULMONARY MASS |
10 |
0.0007 |
| 207 |
PROTHROMBIN TIME PROLONGED |
4 |
0.0007 |
| 208 |
AGE-RELATED MACULAR DEGENERATION |
1 |
0.0007 |
| 209 |
ANAEMIA |
125 |
0.0007 |
| 210 |
MEAN CELL VOLUME DECREASED |
1 |
0.0006 |
| 211 |
COAGULATION TIME PROLONGED |
1 |
0.0006 |
| 212 |
GASTROINTESTINAL STOMA COMPLICATION |
1 |
0.0006 |
| 213 |
MUSCULOSKELETAL STIFFNESS |
55 |
0.0006 |
| 214 |
HAEMATOCHEZIA |
34 |
0.0006 |
| 215 |
QUADRIPARESIS |
1 |
0.0006 |
| 216 |
NEPHRITIS |
2 |
0.0006 |
| 217 |
CONTRAINDICATED PRODUCT PRESCRIBED |
1 |
0.0006 |
| 218 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
6 |
0.0006 |
| 219 |
AMYLOIDOSIS |
1 |
0.0006 |
| 220 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 221 |
HAEMOPTYSIS |
15 |
0.0005 |
| 222 |
BLOOD IRON INCREASED |
1 |
0.0005 |
| 223 |
INTERVERTEBRAL DISCITIS |
1 |
0.0005 |
| 224 |
INFUSION RELATED REACTION |
35 |
0.0005 |
| 225 |
MECHANICAL VENTILATION |
1 |
0.0005 |
| 226 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
36 |
0.0005 |
| 227 |
MIOSIS |
4 |
0.0005 |
| 228 |
BREAST DISORDER |
1 |
0.0005 |
| 229 |
ATRIAL THROMBOSIS |
1 |
0.0005 |
| 230 |
INTERNATIONAL NORMALISED RATIO FLUCTUATION |
1 |
0.0005 |
| 231 |
ANAL PRURITUS |
1 |
0.0005 |
| 232 |
SPINA BIFIDA |
1 |
0.0005 |
| 233 |
PLEURAL EFFUSION |
29 |
0.0005 |
| 234 |
NEUROGENIC BLADDER |
1 |
0.0005 |
| 235 |
PULMONARY FIBROSIS |
9 |
0.0005 |
| 236 |
CONSTIPATION |
102 |
0.0005 |
| 237 |
REACTION TO DRUG EXCIPIENTS |
1 |
0.0005 |
| 238 |
OEDEMA PERIPHERAL |
56 |
0.0005 |
| 239 |
OLIGOMENORRHOEA |
1 |
0.0005 |
| 240 |
ABDOMINAL PAIN |
106 |
0.0005 |
| 241 |
SOMNOLENCE |
90 |
0.0004 |
| 242 |
SUSPECTED OFF LABEL USE |
2 |
0.0004 |
| 243 |
VASCULAR DEVICE INFECTION |
2 |
0.0004 |
| 244 |
LICHENOID KERATOSIS |
1 |
0.0004 |
| 245 |
GASTROINTESTINAL DISORDER |
39 |
0.0004 |
| 246 |
REACTION TO EXCIPIENT |
1 |
0.0004 |
| 247 |
FLAT AFFECT |
1 |
0.0004 |
| 248 |
UTERINE DISORDER |
1 |
0.0004 |
| 249 |
SINUS PAIN |
1 |
0.0004 |
| 250 |
ESCHERICHIA BACTERAEMIA |
1 |
0.0004 |
| 251 |
PRURITUS GENITAL |
1 |
0.0004 |
| 252 |
INFREQUENT BOWEL MOVEMENTS |
1 |
0.0004 |
| 253 |
ASTHMA |
44 |
0.0004 |
| 254 |
PHYSICAL DECONDITIONING |
1 |
0.0004 |
| 255 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 256 |
TONSILLITIS |
2 |
0.0004 |
| 257 |
BLOOD LACTIC ACID INCREASED |
2 |
0.0004 |
| 258 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 259 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
1 |
0.0004 |
| 260 |
BREAST SWELLING |
1 |
0.0004 |
| 261 |
LARYNGOSPASM |
1 |
0.0004 |
| 262 |
WEIGHT BEARING DIFFICULTY |
1 |
0.0004 |
| 263 |
DYSPEPSIA |
36 |
0.0004 |
| 264 |
SPEECH DISORDER DEVELOPMENTAL |
1 |
0.0003 |
| 265 |
GASTRIC HAEMORRHAGE |
4 |
0.0003 |
| 266 |
GASTROENTERITIS |
5 |
0.0003 |
| 267 |
PULMONARY PAIN |
1 |
0.0003 |
| 268 |
LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0003 |
| 269 |
ATYPICAL PNEUMONIA |
1 |
0.0003 |
| 270 |
INTRACARDIAC THROMBUS |
1 |
0.0003 |
| 271 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 272 |
CUSHINGOID |
1 |
0.0003 |
| 273 |
HYPOVENTILATION |
1 |
0.0003 |
| 274 |
LYMPHOCYTE COUNT INCREASED |
1 |
0.0003 |
| 275 |
INFUSION SITE HAEMORRHAGE |
1 |
0.0003 |
| 276 |
OTITIS MEDIA |
1 |
0.0003 |
| 277 |
ASPARTATE AMINOTRANSFERASE INCREASED |
16 |
0.0003 |
| 278 |
THERAPEUTIC AGENT TOXICITY |
1 |
0.0003 |
| 279 |
CONDITION AGGRAVATED |
91 |
0.0003 |
| 280 |
PLANTAR FASCIITIS |
1 |
0.0003 |
| 281 |
WOUND DEHISCENCE |
1 |
0.0003 |
| 282 |
CARBOHYDRATE ANTIGEN 125 INCREASED |
1 |
0.0003 |
| 283 |
APLASIA PURE RED CELL |
1 |
0.0003 |
| 284 |
HYPERTENSION |
61 |
0.0003 |
| 285 |
HYPERREFLEXIA |
1 |
0.0003 |
| 286 |
NECROTISING FASCIITIS |
1 |
0.0003 |
| 287 |
SEASONAL ALLERGY |
4 |
0.0003 |
| 288 |
HAEMORRHAGE SUBCUTANEOUS |
1 |
0.0003 |
| 289 |
RENAL TRANSPLANT |
1 |
0.0003 |
| 290 |
LIVER TRANSPLANT |
1 |
0.0003 |
| 291 |
SPONDYLITIS |
1 |
0.0003 |
| 292 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 293 |
THROAT CLEARING |
1 |
0.0003 |
| 294 |
LOSS OF CONTROL OF LEGS |
1 |
0.0003 |
| 295 |
PRODUCT USE IN UNAPPROVED INDICATION |
65 |
0.0003 |
| 296 |
FOOD ALLERGY |
2 |
0.0003 |
| 297 |
BRONCHOPULMONARY ASPERGILLOSIS |
2 |
0.0003 |
| 298 |
FAECES HARD |
1 |
0.0003 |
| 299 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 300 |
EPIGASTRIC DISCOMFORT |
1 |
0.0003 |
| 301 |
HYPOXIA |
9 |
0.0003 |
| 302 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 303 |
HYPERPHAGIA |
1 |
0.0003 |
| 304 |
POST PROCEDURAL INFECTION |
2 |
0.0002 |
| 305 |
DECUBITUS ULCER |
2 |
0.0002 |
| 306 |
ANAPHYLACTOID REACTION |
1 |
0.0002 |
| 307 |
ILEUS |
3 |
0.0002 |
| 308 |
TREMOR |
40 |
0.0002 |
| 309 |
RED CELL DISTRIBUTION WIDTH INCREASED |
1 |
0.0002 |
| 310 |
ONYCHOMADESIS |
1 |
0.0002 |
| 311 |
PYREXIA |
82 |
0.0002 |
| 312 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 313 |
PURULENT DISCHARGE |
1 |
0.0002 |
| 314 |
MELANOCYTIC NAEVUS |
1 |
0.0002 |
| 315 |
ONYCHOMYCOSIS |
1 |
0.0002 |
| 316 |
PARONYCHIA |
1 |
0.0002 |
| 317 |
VULVOVAGINAL DISCOMFORT |
1 |
0.0002 |
| 318 |
PHYSICAL DISABILITY |
1 |
0.0002 |
| 319 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 320 |
GASTROINTESTINAL CARCINOMA |
2 |
0.0002 |
| 321 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 322 |
ACUTE GRAFT VERSUS HOST DISEASE |
1 |
0.0002 |
| 323 |
MENTAL STATUS CHANGES |
6 |
0.0002 |
| 324 |
ROSACEA |
1 |
0.0002 |
| 325 |
SUSPECTED SUICIDE |
1 |
0.0002 |
| 326 |
SPINAL COLUMN STENOSIS |
1 |
0.0002 |
| 327 |
PRE-ECLAMPSIA |
1 |
0.0002 |
| 328 |
RENAL TUBULAR NECROSIS |
2 |
0.0002 |
| 329 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
1 |
0.0002 |
| 330 |
ABDOMINAL TENDERNESS |
1 |
0.0002 |
| 331 |
HYPERNATRAEMIA |
1 |
0.0002 |
| 332 |
NEUTROPHIL COUNT INCREASED |
2 |
0.0002 |
| 333 |
INCREASED UPPER AIRWAY SECRETION |
1 |
0.0002 |
| 334 |
TRISMUS |
1 |
0.0002 |
| 335 |
VARICOSE VEIN |
1 |
0.0002 |
| 336 |
SKIN NECROSIS |
1 |
0.0002 |
| 337 |
CATATONIA |
1 |
0.0002 |
| 338 |
BLOOD POTASSIUM INCREASED |
3 |
0.0002 |
| 339 |
CHOKING SENSATION |
1 |
0.0002 |
| 340 |
BLOOD UREA INCREASED |
3 |
0.0002 |
| 341 |
BLOOD CALCIUM DECREASED |
2 |
0.0002 |
| 342 |
OFF LABEL USE |
153 |
0.0002 |
| 343 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 344 |
MOUTH SWELLING |
1 |
0.0002 |
| 345 |
METABOLIC DISORDER |
1 |
0.0002 |
| 346 |
CHRONIC KIDNEY DISEASE |
13 |
0.0002 |
| 347 |
ERYTHEMA |
35 |
0.0002 |
| 348 |
WHEEZING |
10 |
0.0002 |
| 349 |
NEUROLEPTIC MALIGNANT SYNDROME |
2 |
0.0002 |
| 350 |
ODYNOPHAGIA |
1 |
0.0002 |
| 351 |
SQUAMOUS CELL CARCINOMA OF SKIN |
1 |
0.0002 |
| 352 |
LARYNGEAL OEDEMA |
1 |
0.0002 |
| 353 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 354 |
HYPERCALCAEMIA |
2 |
0.0002 |
| 355 |
WEIGHT DECREASED |
45 |
0.0002 |
| 356 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 357 |
MYDRIASIS |
2 |
0.0002 |
| 358 |
INCOHERENT |
1 |
0.0002 |
| 359 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 360 |
SOMNAMBULISM |
1 |
0.0002 |
| 361 |
HAEMATOCRIT DECREASED |
3 |
0.0002 |
| 362 |
VOMITING |
71 |
0.0002 |
| 363 |
UPPER LIMB FRACTURE |
3 |
0.0002 |
| 364 |
TERMINAL STATE |
1 |
0.0001 |
| 365 |
GASTROOESOPHAGEAL REFLUX DISEASE |
12 |
0.0001 |
| 366 |
METASTASES TO LYMPH NODES |
1 |
0.0001 |
| 367 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 368 |
GENERAL PHYSICAL CONDITION ABNORMAL |
1 |
0.0001 |
| 369 |
ONYCHOCLASIS |
1 |
0.0001 |
| 370 |
PRODUCT DOSE OMISSION ISSUE |
42 |
0.0001 |
| 371 |
HYPERKALAEMIA |
5 |
0.0001 |
| 372 |
PAPULE |
1 |
0.0001 |
| 373 |
HAND FRACTURE |
1 |
0.0001 |
| 374 |
THERMAL BURN |
1 |
0.0001 |
| 375 |
NAUSEA |
111 |
0.0001 |
| 376 |
NEUTROPENIC SEPSIS |
1 |
0.0001 |
| 377 |
RED BLOOD CELL COUNT DECREASED |
4 |
0.0001 |
| 378 |
PARALYSIS |
2 |
0.0001 |
| 379 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 380 |
PAIN |
85 |
0.0001 |
| 381 |
ASTHENIA |
52 |
0.0001 |
| 382 |
TONGUE DISORDER |
1 |
0.0001 |
| 383 |
FAECES SOFT |
1 |
0.0001 |
| 384 |
RASH PUSTULAR |
1 |
0.0001 |
| 385 |
SENSITIVE SKIN |
1 |
0.0001 |
| 386 |
BLOOD POTASSIUM DECREASED |
4 |
0.0001 |
| 387 |
PAROSMIA |
1 |
0.0001 |
| 388 |
HEADACHE |
82 |
0.0001 |
| 389 |
SKIN DISCOLOURATION |
6 |
0.0001 |
| 390 |
PHARYNGEAL OEDEMA |
2 |
0.0001 |
| 391 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 392 |
DIFFUSE LARGE B-CELL LYMPHOMA |
1 |
0.0001 |
| 393 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 394 |
APNOEA |
1 |
0.0001 |
| 395 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 396 |
ELECTROCARDIOGRAM ABNORMAL |
1 |
0.0001 |
| 397 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 398 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 399 |
MUSCLE DISORDER |
1 |
0.0001 |
| 400 |
ENCEPHALOPATHY |
3 |
0.0001 |
| 401 |
POLYURIA |
1 |
0.0001 |
| 402 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
22 |
0.0001 |
| 403 |
ABNORMAL FAECES |
1 |
0.0001 |
| 404 |
HYPERAESTHESIA |
1 |
0.0001 |
| 405 |
LETHARGY |
7 |
0.0001 |
| 406 |
MENSTRUAL DISORDER |
1 |
0.0001 |
| 407 |
LIP SWELLING |
4 |
0.0001 |
| 408 |
SKIN PLAQUE |
1 |
0.0001 |
| 409 |
PNEUMONIA |
38 |
0.0001 |
| 410 |
MYOPATHY |
1 |
0.0001 |
| 411 |
CARDIAC MURMUR |
1 |
0.0001 |
| 412 |
PYELONEPHRITIS |
1 |
0.0001 |
| 413 |
RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 414 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 415 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 416 |
TUMOUR LYSIS SYNDROME |
1 |
0.0001 |
| 417 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 418 |
ANGIOEDEMA |
5 |
0.0001 |
| 419 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 420 |
FACIAL PAIN |
1 |
0.0001 |
| 421 |
DYSPNOEA |
63 |
0.0001 |
| 422 |
DEVELOPMENTAL DELAY |
1 |
0.0001 |
| 423 |
UROSEPSIS |
1 |
0.0001 |
| 424 |
AGRANULOCYTOSIS |
2 |
0.0001 |
| 425 |
HEPATIC ENCEPHALOPATHY |
1 |
0.0001 |
| 426 |
NEPHROPATHY |
1 |
0.0001 |
| 427 |
FLANK PAIN |
1 |
0.0001 |
| 428 |
LACERATION |
1 |
0.0001 |
| 429 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 430 |
HYPOCALCAEMIA |
2 |
0.0001 |
| 431 |
FRACTURE |
2 |
0.0001 |
| 432 |
MALAISE |
46 |
0.0001 |
| 433 |
POST PROCEDURAL COMPLICATION |
2 |
0.0001 |
| 434 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 435 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 436 |
HOSPICE CARE |
1 |
0.0001 |
| 437 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
4 |
0.0001 |
| 438 |
OVARIAN CYST |
1 |
0.0001 |
| 439 |
POOR QUALITY DEVICE USED |
1 |
0.0001 |
| 440 |
DRY THROAT |
1 |
0.0001 |
| 441 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 442 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 443 |
EYE DISCHARGE |
1 |
0.0001 |
| 444 |
SWOLLEN TONGUE |
3 |
0.0001 |
| 445 |
TRANSFUSION |
1 |
0.0001 |
| 446 |
MOUTH ULCERATION |
2 |
0.0001 |
| 447 |
SUDDEN DEATH |
1 |
0.0001 |
| 448 |
CLOSTRIDIUM DIFFICILE COLITIS |
1 |
0.0001 |
| 449 |
RETCHING |
2 |
0.0001 |
| 450 |
BREAST PAIN |
1 |
0.0001 |
| 451 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 452 |
SWELLING FACE |
6 |
0.0001 |
| 453 |
SKIN LACERATION |
1 |
0.0001 |
| 454 |
TOOTH FRACTURE |
1 |
0.0001 |
| 455 |
FUNGAL INFECTION |
3 |
0.0001 |
| 456 |
MALNUTRITION |
1 |
0.0001 |
| 457 |
BLISTER |
5 |
0.0001 |
| 458 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 459 |
SCAB |
1 |
0.0001 |
| 460 |
NEPHROLITHIASIS |
4 |
0.0001 |
| 461 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 462 |
RENAL DISORDER |
4 |
0.0001 |
| 463 |
SPINAL PAIN |
1 |
0.0001 |
| 464 |
CHOLECYSTITIS |
1 |
0.0001 |
| 465 |
HEPATITIS C |
1 |
0.0001 |
| 466 |
DRUG EFFECT INCOMPLETE |
3 |
0.0001 |
| 467 |
C-REACTIVE PROTEIN INCREASED |
3 |
0.0001 |
| 468 |
BURSITIS |
1 |
0.0001 |
| 469 |
PHARYNGITIS |
1 |
0.0001 |
| 470 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
2 |
0.0001 |
| 471 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 472 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 473 |
DRUG INEFFECTIVE |
105 |
0.0001 |
| 474 |
BRAIN OEDEMA |
1 |
0.0001 |
| 475 |
ACUTE KIDNEY INJURY |
12 |
0.0001 |
| 476 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 477 |
ECZEMA |
4 |
0.0001 |
| 478 |
ADVERSE REACTION |
1 |
0.0001 |
| 479 |
RENAL FAILURE |
10 |
0.0001 |
| 480 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 481 |
SINUS CONGESTION |
1 |
0.0001 |
| 482 |
DEVICE MECHANICAL ISSUE |
1 |
0.0001 |
| 483 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
1 |
0.0001 |
| 484 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 485 |
DEMENTIA |
2 |
0.0001 |
| 486 |
MASS |
1 |
0.0001 |
| 487 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 488 |
DIALYSIS |
1 |
0.0001 |
| 489 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 490 |
BRONCHOSPASM |
1 |
0.0001 |
| 491 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
2 |
0.0001 |
| 492 |
HYPOKINESIA |
1 |
0.0001 |
| 493 |
FLUID OVERLOAD |
1 |
0.0001 |
| 494 |
DEHYDRATION |
9 |
0.0001 |
| 495 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 496 |
RENAL INJURY |
2 |
0.0001 |
| 497 |
COLON CANCER |
1 |
0.0001 |
| 498 |
FEELING HOT |
4 |
0.0001 |
| 499 |
THYROID DISORDER |
1 |
0.0001 |
| 500 |
LYMPHOMA |
1 |
0.0001 |
| 501 |
ANKLE FRACTURE |
1 |
0.0001 |
| 502 |
LUNG INFECTION |
1 |
0.0001 |
| 503 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 504 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 505 |
PNEUMOTHORAX |
1 |
0.0001 |
| 506 |
DRUG INTERACTION |
10 |
0.0001 |
| 507 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 508 |
CYSTITIS |
2 |
0.0001 |
| 509 |
ABSCESS |
1 |
0.0001 |
| 510 |
NIGHT SWEATS |
2 |
0.0001 |
| 511 |
INTERSTITIAL LUNG DISEASE |
3 |
0.0001 |
| 512 |
FATIGUE |
48 |
0.0001 |
| 513 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 514 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 515 |
GAIT INABILITY |
2 |
0.0001 |
| 516 |
PERICARDITIS |
1 |
0.0001 |
| 517 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 518 |
CANDIDA INFECTION |
1 |
0.0001 |
| 519 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 520 |
HAEMATURIA |
2 |
0.0001 |
| 521 |
MULTI-ORGAN FAILURE |
1 |
0.0001 |
| 522 |
RASH MACULAR |
2 |
0.0001 |
| 523 |
NEUROTOXICITY |
1 |
0.0001 |
| 524 |
COUGH |
16 |
0.0001 |
| 525 |
METASTASES TO LIVER |
1 |
0.0001 |
| 526 |
LYMPHADENOPATHY |
2 |
0.0001 |
| 527 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 528 |
THIRST |
1 |
0.0001 |
| 529 |
RASH PRURITIC |
3 |
0.0001 |
| 530 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 531 |
BONE DISORDER |
1 |
0.0001 |
| 532 |
ACCIDENTAL OVERDOSE |
2 |
0.0001 |
| 533 |
MEDICATION ERROR |
3 |
0.0001 |
| 534 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 535 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 536 |
HEPATIC CIRRHOSIS |
1 |
0.0001 |
| 537 |
PHOTOPHOBIA |
1 |
0.0001 |
| 538 |
DYSARTHRIA |
2 |
0.0001 |
| 539 |
FLATULENCE |
3 |
0.0001 |
| 540 |
FOOT FRACTURE |
1 |
0.0001 |
| 541 |
DYSPHAGIA |
5 |
0.0001 |
| 542 |
PROTEINURIA |
1 |
0.0001 |
| 543 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 544 |
WHITE BLOOD CELL COUNT INCREASED |
2 |
0.0001 |
| 545 |
SKIN FISSURES |
1 |
0.0001 |
| 546 |
KIDNEY INFECTION |
1 |
0.0001 |
| 547 |
DISORIENTATION |
2 |
0.0001 |
| 548 |
HEART RATE INCREASED |
5 |
0.0001 |
| 549 |
CATARACT |
3 |
0.0001 |
| 550 |
PREGNANCY |
1 |
0.0000 |
| 551 |
CONFUSIONAL STATE |
8 |
0.0000 |
| 552 |
STOMATITIS |
3 |
0.0000 |
| 553 |
FEEDING DISORDER |
1 |
0.0000 |
| 554 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 555 |
ABDOMINAL PAIN UPPER |
10 |
0.0000 |
| 556 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 557 |
DERMATITIS |
1 |
0.0000 |
| 558 |
WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 559 |
RENAL IMPAIRMENT |
4 |
0.0000 |
| 560 |
RHINORRHOEA |
3 |
0.0000 |
| 561 |
HOSPITALISATION |
7 |
0.0000 |
| 562 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 563 |
HYPOTENSION |
9 |
0.0000 |
| 564 |
GLOSSODYNIA |
1 |
0.0000 |
| 565 |
RASH PAPULAR |
1 |
0.0000 |
| 566 |
SNEEZING |
1 |
0.0000 |
| 567 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 568 |
OROPHARYNGEAL PAIN |
4 |
0.0000 |
| 569 |
DEATH |
37 |
0.0000 |
| 570 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 571 |
BURNING SENSATION |
3 |
0.0000 |
| 572 |
COMA |
2 |
0.0000 |
| 573 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 574 |
LOCALISED INFECTION |
1 |
0.0000 |
| 575 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 576 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 577 |
BRONCHITIS |
3 |
0.0000 |
| 578 |
ABASIA |
1 |
0.0000 |
| 579 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 580 |
LEUKOPENIA |
2 |
0.0000 |
| 581 |
UNEVALUABLE EVENT |
3 |
0.0000 |
| 582 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 583 |
DRUG RESISTANCE |
1 |
0.0000 |
| 584 |
UNRESPONSIVE TO STIMULI |
1 |
0.0000 |
| 585 |
HAEMATOMA |
1 |
0.0000 |
| 586 |
DIPLOPIA |
1 |
0.0000 |
| 587 |
HAEMORRHAGE |
4 |
0.0000 |
| 588 |
DEAFNESS |
1 |
0.0000 |
| 589 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 590 |
ANHEDONIA |
1 |
0.0000 |
| 591 |
GASTRITIS |
1 |
0.0000 |
| 592 |
HYPERSENSITIVITY |
7 |
0.0000 |
| 593 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 594 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 595 |
WHITE BLOOD CELL COUNT DECREASED |
4 |
0.0000 |
| 596 |
OEDEMA |
2 |
0.0000 |
| 597 |
LIMB INJURY |
1 |
0.0000 |
| 598 |
NEUTROPENIA |
5 |
0.0000 |
| 599 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 600 |
WOUND |
1 |
0.0000 |
| 601 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 602 |
INCORRECT DRUG ADMINISTRATION DURATION |
1 |
0.0000 |
| 603 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 604 |
CONVULSION |
2 |
0.0000 |
| 605 |
SEIZURE |
4 |
0.0000 |
| 606 |
DYSSTASIA |
1 |
0.0000 |
| 607 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 608 |
TACHYCARDIA |
3 |
0.0000 |
| 609 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 610 |
VERTIGO |
2 |
0.0000 |
| 611 |
BLOOD PRESSURE INCREASED |
5 |
0.0000 |
| 612 |
INJECTION SITE RASH |
1 |
0.0000 |
| 613 |
DRUG ADMINISTRATION ERROR |
1 |
0.0000 |
| 614 |
CARDIAC DISORDER |
3 |
0.0000 |
| 615 |
PARAESTHESIA |
5 |
0.0000 |
| 616 |
METABOLIC ACIDOSIS |
1 |
0.0000 |
| 617 |
WEIGHT INCREASED |
7 |
0.0000 |
| 618 |
LOSS OF CONSCIOUSNESS |
4 |
0.0000 |
| 619 |
AMNESIA |
2 |
0.0000 |
| 620 |
IMPAIRED HEALING |
1 |
0.0000 |
| 621 |
EYE DISORDER |
1 |
0.0000 |
| 622 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 623 |
VIRAL INFECTION |
1 |
0.0000 |
| 624 |
SKIN DISORDER |
1 |
0.0000 |
| 625 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 626 |
ANGER |
1 |
0.0000 |
| 627 |
URINARY TRACT INFECTION |
5 |
0.0000 |
| 628 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 629 |
GASTRIC DISORDER |
1 |
0.0000 |
| 630 |
HEART RATE DECREASED |
1 |
0.0000 |
| 631 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 632 |
MOBILITY DECREASED |
2 |
0.0000 |
| 633 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 634 |
PANIC ATTACK |
1 |
0.0000 |
| 635 |
RESTLESSNESS |
1 |
0.0000 |
| 636 |
DYSURIA |
1 |
0.0000 |
| 637 |
NASOPHARYNGITIS |
5 |
0.0000 |
| 638 |
INFLUENZA |
3 |
0.0000 |
| 639 |
EYE SWELLING |
1 |
0.0000 |
| 640 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 641 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 642 |
EPISTAXIS |
2 |
0.0000 |
| 643 |
HALLUCINATION |
2 |
0.0000 |
| 644 |
PRURITUS |
10 |
0.0000 |
| 645 |
PERIPHERAL SWELLING |
4 |
0.0000 |
| 646 |
PLASMA CELL MYELOMA |
1 |
0.0000 |
| 647 |
ARTHRITIS |
2 |
0.0000 |
| 648 |
INJECTION SITE BRUISING |
2 |
0.0000 |
| 649 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 650 |
DYSKINESIA |
1 |
0.0000 |
| 651 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 652 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 653 |
CARDIAC ARREST |
2 |
0.0000 |
| 654 |
DRUG DOSE OMISSION |
4 |
0.0000 |
| 655 |
DRUG ABUSE |
2 |
0.0000 |
| 656 |
POLLAKIURIA |
1 |
0.0000 |
| 657 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 658 |
TOXICITY TO VARIOUS AGENTS |
4 |
0.0000 |
| 659 |
SKIN EXFOLIATION |
2 |
0.0000 |
| 660 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 661 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 662 |
DIARRHOEA |
15 |
0.0000 |
| 663 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 664 |
DEVICE DISLOCATION |
1 |
0.0000 |
| 665 |
DRY SKIN |
3 |
0.0000 |
| 666 |
TINNITUS |
1 |
0.0000 |
| 667 |
HYPOKALAEMIA |
1 |
0.0000 |
| 668 |
ARTHRALGIA |
9 |
0.0000 |
| 669 |
CHEST PAIN |
4 |
0.0000 |
| 670 |
DECREASED APPETITE |
5 |
0.0000 |
| 671 |
MIGRAINE |
2 |
0.0000 |
| 672 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 673 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 674 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 675 |
HYPOAESTHESIA |
3 |
0.0000 |
| 676 |
FLUID RETENTION |
1 |
0.0000 |
| 677 |
MALIGNANT NEOPLASM PROGRESSION |
2 |
0.0000 |
| 678 |
SINUSITIS |
2 |
0.0000 |
| 679 |
THERAPY CESSATION |
1 |
0.0000 |
| 680 |
ILLNESS |
2 |
0.0000 |
| 681 |
INFLAMMATION |
1 |
0.0000 |
| 682 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 683 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 684 |
BRADYCARDIA |
1 |
0.0000 |
| 685 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 686 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 687 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 688 |
FALL |
6 |
0.0000 |
| 689 |
URTICARIA |
3 |
0.0000 |
| 690 |
PANCYTOPENIA |
1 |
0.0000 |
| 691 |
MYALGIA |
3 |
0.0000 |
| 692 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 693 |
DYSPHONIA |
1 |
0.0000 |
| 694 |
NASAL CONGESTION |
1 |
0.0000 |
| 695 |
PAIN IN EXTREMITY |
5 |
0.0000 |
| 696 |
FEELING ABNORMAL |
4 |
0.0000 |
| 697 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 698 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 699 |
RASH |
7 |
0.0000 |
| 700 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 701 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 702 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 703 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 704 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 705 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 706 |
OVERDOSE |
3 |
0.0000 |
| 707 |
INFECTION |
2 |
0.0000 |
| 708 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 709 |
AGITATION |
1 |
0.0000 |
| 710 |
HOT FLUSH |
1 |
0.0000 |
| 711 |
BACK PAIN |
3 |
0.0000 |
| 712 |
DRUG DOSE OMISSION BY DEVICE |
1 |
0.0000 |
| 713 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 714 |
CARDIAC FAILURE |
1 |
0.0000 |
| 715 |
PROSTATE CANCER |
1 |
0.0000 |
| 716 |
DIZZINESS |
6 |
0.0000 |
| 717 |
COMPLETED SUICIDE |
1 |
0.0000 |
| 718 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 719 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 720 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 721 |
BALANCE DISORDER |
1 |
0.0000 |
| 722 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 723 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 724 |
COVID-19 |
2 |
0.0000 |
| 725 |
DRUG WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 726 |
INSOMNIA |
3 |
0.0000 |
| 727 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 728 |
MUSCLE SPASMS |
2 |
0.0000 |
| 729 |
ANXIETY |
3 |
0.0000 |
| 730 |
ALOPECIA |
2 |
0.0000 |
| 731 |
SYNCOPE |
1 |
0.0000 |
| 732 |
FLUSHING |
1 |
0.0000 |
| 733 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 734 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 735 |
PALPITATIONS |
1 |
0.0000 |
| 736 |
CHILLS |
1 |
0.0000 |
| 737 |
JOINT SWELLING |
1 |
0.0000 |
| 738 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 739 |
HYPERHIDROSIS |
1 |
0.0000 |
| 740 |
PSORIASIS |
1 |
0.0000 |
| 741 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 742 |
VISION BLURRED |
1 |
0.0000 |
| 743 |
INJECTION SITE PAIN |
2 |
0.0000 |
| 744 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 745 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 746 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 747 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |